vs
Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and AbCellera Biologics Inc. (ABCL). Click either name above to swap in a different company.
ATLANTIC AMERICAN CORP is the larger business by last-quarter revenue ($53.8M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). ATLANTIC AMERICAN CORP runs the higher net margin — 1.1% vs -19.9%, a 21.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 20.8%). ATLANTIC AMERICAN CORP produced more free cash flow last quarter ($6.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 7.2%).
The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
AAME vs ABCL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $44.9M |
| Net Profit | $577.0K | $-8.9M |
| Gross Margin | — | — |
| Operating Margin | 1.4% | -63.7% |
| Net Margin | 1.1% | -19.9% |
| Revenue YoY | 20.8% | 788.4% |
| Net Profit YoY | 128.9% | 73.9% |
| EPS (diluted) | $0.02 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $44.9M | ||
| Q3 25 | $53.8M | $9.0M | ||
| Q2 25 | $55.3M | $17.1M | ||
| Q1 25 | $50.1M | $4.2M | ||
| Q4 24 | $49.0M | $5.0M | ||
| Q3 24 | $44.5M | $6.5M | ||
| Q2 24 | $47.7M | $7.3M | ||
| Q1 24 | $47.0M | $10.0M |
| Q4 25 | — | $-8.9M | ||
| Q3 25 | $577.0K | $-57.1M | ||
| Q2 25 | $3.3M | $-34.7M | ||
| Q1 25 | $802.0K | $-45.6M | ||
| Q4 24 | $412.0K | — | ||
| Q3 24 | $-2.0M | $-51.1M | ||
| Q2 24 | $-684.0K | $-36.9M | ||
| Q1 24 | $-2.0M | $-40.6M |
| Q4 25 | — | -63.7% | ||
| Q3 25 | 1.4% | -851.8% | ||
| Q2 25 | 7.6% | -290.2% | ||
| Q1 25 | 2.1% | -1479.6% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | -5.5% | -1439.4% | ||
| Q2 24 | -1.8% | -1276.2% | ||
| Q1 24 | -5.3% | -551.5% |
| Q4 25 | — | -19.9% | ||
| Q3 25 | 1.1% | -637.8% | ||
| Q2 25 | 6.0% | -203.3% | ||
| Q1 25 | 1.6% | -1077.2% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | -4.5% | -785.4% | ||
| Q2 24 | -1.4% | -504.3% | ||
| Q1 24 | -4.3% | -408.0% |
| Q4 25 | — | $-0.03 | ||
| Q3 25 | $0.02 | $-0.19 | ||
| Q2 25 | $0.15 | $-0.12 | ||
| Q1 25 | $0.03 | $-0.15 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.10 | $-0.17 | ||
| Q2 24 | $-0.04 | $-0.13 | ||
| Q1 24 | $-0.10 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.4M | $128.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $109.5M | $966.9M |
| Total Assets | $430.9M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $128.5M | ||
| Q3 25 | $34.4M | $83.2M | ||
| Q2 25 | $46.4M | $92.4M | ||
| Q1 25 | $35.9M | $159.3M | ||
| Q4 24 | $35.6M | $156.3M | ||
| Q3 24 | $23.0M | $126.6M | ||
| Q2 24 | $21.2M | $148.3M | ||
| Q1 24 | $21.2M | $123.6M |
| Q4 25 | — | $966.9M | ||
| Q3 25 | $109.5M | $964.0M | ||
| Q2 25 | $106.2M | $1.0B | ||
| Q1 25 | $102.4M | $1.0B | ||
| Q4 24 | $99.6M | $1.1B | ||
| Q3 24 | $105.8M | $1.1B | ||
| Q2 24 | $100.7M | $1.1B | ||
| Q1 24 | $102.8M | $1.1B |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $430.9M | $1.4B | ||
| Q2 25 | $429.3M | $1.4B | ||
| Q1 25 | $388.4M | $1.3B | ||
| Q4 24 | $393.4M | $1.4B | ||
| Q3 24 | $387.0M | $1.4B | ||
| Q2 24 | $386.0M | $1.4B | ||
| Q1 24 | $365.8M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $-34.7M |
| Free Cash FlowOCF − Capex | $6.6M | $-44.6M |
| FCF MarginFCF / Revenue | 12.3% | -99.4% |
| Capex IntensityCapex / Revenue | 0.1% | 21.9% |
| Cash ConversionOCF / Net Profit | 11.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.3M | $-174.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.7M | ||
| Q3 25 | $6.6M | $-52.6M | ||
| Q2 25 | $9.3M | $-32.4M | ||
| Q1 25 | $-722.0K | $-11.6M | ||
| Q4 24 | $4.8M | $-108.6M | ||
| Q3 24 | $90.0K | $-28.9M | ||
| Q2 24 | $416.0K | $-30.0M | ||
| Q1 24 | $-5.3M | $-41.7M |
| Q4 25 | — | $-44.6M | ||
| Q3 25 | $6.6M | $-61.5M | ||
| Q2 25 | $9.1M | $-45.8M | ||
| Q1 25 | $-986.0K | $-22.2M | ||
| Q4 24 | $4.6M | $-187.0M | ||
| Q3 24 | $58.0K | $-47.4M | ||
| Q2 24 | $361.0K | $-50.1M | ||
| Q1 24 | $-5.4M | $-65.8M |
| Q4 25 | — | -99.4% | ||
| Q3 25 | 12.3% | -687.0% | ||
| Q2 25 | 16.5% | -267.9% | ||
| Q1 25 | -2.0% | -524.0% | ||
| Q4 24 | 9.3% | -3702.8% | ||
| Q3 24 | 0.1% | -728.4% | ||
| Q2 24 | 0.8% | -683.8% | ||
| Q1 24 | -11.4% | -661.5% |
| Q4 25 | — | 21.9% | ||
| Q3 25 | 0.1% | 99.7% | ||
| Q2 25 | 0.3% | 78.2% | ||
| Q1 25 | 0.5% | 251.1% | ||
| Q4 24 | 0.5% | 1552.7% | ||
| Q3 24 | 0.1% | 284.6% | ||
| Q2 24 | 0.1% | 274.6% | ||
| Q1 24 | 0.1% | 242.5% |
| Q4 25 | — | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 2.80× | — | ||
| Q1 25 | -0.90× | — | ||
| Q4 24 | 11.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
ABCL
Segment breakdown not available.
